Category: NASDAQ:ACAD

Steven Cohen Keeps Buying Acadia Pharmaceuticals, A Stock Down By Half This Year

By GuruFocus, Contributor in Forbes, NASDAQ:ACAD
June 20, 2018

The FDA said it would re-examine the company’s only drug sending shares tumbling